VYGR
Voyager Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.09
+1.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.23x
- Price / sales
- 5.53x
- Price / cash flow
- -1.58x
Enterprise value
- Enterprise value
- $106.6M
- EV / sales
- 3.09x
- EV / EBITDA
- -1.04x
- EV / EBIT
- -0.91x
- Market cap
- $190.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026